Matrix metalloprotease 16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells

Development Growth and Differentiation

Volumn 54, Issue 2, 2012, Pages 216-226

  Astarci, Erhan ^a   Erson Bensan, Ayşe E ^a   Banerjee, Sreeparna ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Caco 2; Colon; Differentiation; miR 146a; MMP16

Indexed keywords

GELATIN; GELATINASE; LUCIFERASE; MATRIGEL; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; MICRORNA; MICRORNA 146A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; ZYMOGRAPHY;

ALKALINE PHOSPHATASE; BLOTTING, WESTERN; CACO-2 CELLS; CELL DIFFERENTIATION; HT29 CELLS; HUMANS; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 2; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84857501960     PISSN: 00121592     EISSN: 1440169X     Source Type: Journal    
DOI: 10.1111/j.1440-169X.2011.01324.x     Document Type: Article

References (30)

1. Ali, S., Almhanna, K., Chen, W., Philip, P. A. & Sarkar, F. H. 2010. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am. J. Transl. Res. 3, 28-47.
2. Arai, I., Nagano, H., Kondo, M., Yamamoto, H., Hiraoka, N., Sugita, Y., Ota, H., Yoshioka, S., Nakamura, M., Wada, H., Damdinsuren, B., Kato, H., Marubashi, S., Miyamoto, A., Takeda, Y., Dono, K., Umeshita, K., Nakamori, S., Wakasa, K., Sakon, M. & Monden, M. 2007. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion. Hepatogastroenterology 54, 167-171.
3. Beaurepaire, C., Smyth, D. & Mckay, D. M. 2009. Interferon-gamma regulation of intestinal epithelial permeability. J. Interferon Cytokine Res. 29, 133-144.
4. Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J. & Benz, C. C. 2008. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 5643-5647.
5. Chassin, C., Kocur, M., Pott, J., Duerr, C. U., Gütle, D., Lotz, M. & Hornef, M. W. 2010. miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe 8, 358-368.
6. Cimen, I., Tuncay, S. & Banerjee, S. 2009. 15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29. Cancer Sci. 100, 2283-2291.
7. Cui, M., Zhao, Y., Hance, K. W., Shao, A., Wood, R. J. & Fleet, J. C. 2009. Effects of MAPK signaling on 1, 25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2. J. Cell Physiol. 219, 132-142.
8. Daja, M. M., Niu, X., Zhao, Z., Brown, J. M. & Russell, P. J. 2003. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prostate Cancer Prostatic Dis. 6, 15-26.
9. Dalmasso, G., Nguyen, H. T., Yan, Y., Laroui, H., Srinivasan, S., Sitaraman, S.V. & Merlin, D. 2010. MicroRNAs determine human intestinal epithelial cell fate. Differentiation 80, 147-154.
10. Erson, A. E. & Petty, E. M. 2008. MicroRNAs in development and disease. Clin. Genet. 74, 296-306.
11. Friedman, R., Farh, K., Burge, C. & Bartel, D. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105.
12. Hermanek, P. 1995. pTNM and residual tumor classifications: Problems of assessment and prognostic significance. World J. Surg. 19, 184-190.
13. Hino, K., Tsuchiya, K., Fukao, T., Kiga, K., Okamoto, R., Kanai, T. & Watanabe, M. 2008. Inducible expression of microRNA-194 is regulated by HNF-1alpha during intestinal epithelial cell differentiation. RNA 14, 1433-1442.
14. Hotary, K., Li, X. Y., Allen, E., Stevens, S. L. & Weiss, S. J. 2006. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 20, 2673-2686.
15. Humphries, A. & Wright, N. A. 2008. Colonic crypt organization and tumorigenesis. Nat. Rev. Cancer 8, 415-424.
16. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U. & Segal, E. 2007. The role of site accessibility in microRNA target recognition. Nat. Genet. 39, 1278-1284.
17. Kessenbrock, K., Plaks, V. & Werb, Z. 2010. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141, 52-67.
18. Kogo, R., Mimori, K., Tanaka, F., Komune, S. & Mori, M. 2011. Clinical significance of miR-146a in gastric cancer cases. Clin. Cancer Res. 17, 4277-4284. United States.
19. Lin, S. L., Chiang, A., Chang, D. & Ying, S. Y. 2008. Loss of mir-146a function in hormone-refractory prostate cancer. RNA 14, 417-424.
20. Lowy, A. M., Clements, W. M., Bishop, J., Kong, L., Bonney, T., Sisco, K., Aronow, B., Fenoglio-Preiser, C. & Groden, J. 2006. Beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res. 66, 4734-4741.
21. Mckenna, L. B., Schug, J., Vourekas, A., McKenna, J.B., Bramswig, N.C., Friedman, J.R. & Kaestner, K.H. 2010. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139, 1654-1664.
22. Nakada, M., Nakamura, H., Ikeda, E., Fujimoto, N., Yamashita, J., Sato, H., Seiki, M. & Okada, Y. 1999. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am. J. Pathol. 154, 417-428.
23. Nakamura, H., Ueno, H., Yamashita, K., Shimada, T., Yamamoto, E., Noguchi, M., Fujimoto, N., Sato, H., Seiki, M. & Okada, Y. 1999. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Cancer Res. 59, 467-473.
24. Ohnishi, Y., Tajima, S. & Ishibashi, A. 2001. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Eur. J. Dermatol. 11, 420-423.
25. Pinto, M. 1983. Enterocyte like differentiation and polarization of the human colon carcioma cell line Caco-2. Biol. Cell 47, 323-330.
26. Polyak, K. & Weinberg, R. A. 2009. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273.
27. Rowe, R. G. & Weiss, S. J. 2008. Breaching the basement membrane: Who, when and how? Trends Cell Biol. 18, 560-574.
28. Simon-Assmann, P., Turck, N., Sidhoum-Jenny, M., Gradwohl, G. & Kedinger, M. 2007. In vitro models of intestinal epithelial cell differentiation. Cell Biol. Toxicol. 23, 241-256.
29. Taganov, K., Boldin, M., Chang, K. & Baltimore, D. 2006. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl Acad. Sci. USA 103, 12481-12486.
30. Xia, H., Qi, Y., Ng, S. S., Chen, X., Li, D., Chen, S., Ge, R., Jiang, S., Li, G., Chen, Y., He, M. L., Kung, H. F., Lai, L. & Lin, M. C. 2009. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 1269, 158-165.